200 related articles for article (PubMed ID: 31364370)
1. Chemokine signaling axis between endothelial and myeloid cells regulates development of pulmonary hypertension associated with pulmonary fibrosis and hypoxia.
Oliveira AC; Fu C; Lu Y; Williams MA; Pi L; Brantly ML; Ventetuolo CE; Raizada MK; Mehrad B; Scott EW; Bryant AJ
Am J Physiol Lung Cell Mol Physiol; 2019 Oct; 317(4):L434-L444. PubMed ID: 31364370
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension.
Bryant AJ; Shenoy V; Fu C; Marek G; Lorentsen KJ; Herzog EL; Brantly ML; Avram D; Scott EW
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):170-180. PubMed ID: 28862882
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.
Bryant AJ; Mehrad B; Brusko TM; West JD; Moldawer LL
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081463
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
[TBL] [Abstract][Full Text] [Related]
5. Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.
Yang J; Yan C; Vilgelm AE; Chen SC; Ayers GD; Johnson CA; Richmond A
Cancer Immunol Res; 2021 Feb; 9(2):200-213. PubMed ID: 33177110
[TBL] [Abstract][Full Text] [Related]
6. Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension.
Bryant AJ; Carrick RP; McConaha ME; Jones BR; Shay SD; Moore CS; Blackwell TR; Gladson S; Penner NL; Burman A; Tanjore H; Hemnes AR; Karwandyar AK; Polosukhin VV; Talati MA; Dong HJ; Gleaves LA; Carrier EJ; Gaskill C; Scott EW; Majka SM; Fessel JP; Haase VH; West JD; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L249-62. PubMed ID: 26637636
[TBL] [Abstract][Full Text] [Related]
7. Flk1 Deficiency and Hypoxia Synergistically Promote Endothelial Dysfunction, Vascular Remodeling, and Pulmonary Hypertension.
Akiyama T; Sadahiro T; Yamada Y; Fujita R; Abe Y; Nakano K; Honda S; Ema M; Kubota Y; Sakai S; Hizawa N; Ieda M
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1668-1683. PubMed ID: 37534464
[TBL] [Abstract][Full Text] [Related]
8. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism.
Yamaji-Kegan K; Su Q; Angelini DJ; Myers AC; Cheadle C; Johns RA
J Immunol; 2010 Nov; 185(9):5539-48. PubMed ID: 20889544
[TBL] [Abstract][Full Text] [Related]
10. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
Hu CJ; Poth JM; Zhang H; Flockton A; Laux A; Kumar S; McKeon B; Mouradian G; Li M; Riddle S; Pugliese SC; Brown RD; Wallace EM; Graham BB; Frid MG; Stenmark KR
Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515405
[TBL] [Abstract][Full Text] [Related]
11. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension.
Federti E; Matté A; Ghigo A; Andolfo I; James C; Siciliano A; Leboeuf C; Janin A; Manna F; Choi SY; Iolascon A; Beneduce E; Melisi D; Kim DW; Levi S; De Franceschi L
Free Radic Biol Med; 2017 Nov; 112():376-386. PubMed ID: 28801243
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
[TBL] [Abstract][Full Text] [Related]
15. The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions.
Nakahara M; Ito H; Skinner JT; Lin Q; Tamosiuniene R; Nicolls MR; Keegan AD; Johns RA; Yamaji-Kegan K
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L416-L428. PubMed ID: 34189964
[TBL] [Abstract][Full Text] [Related]
16. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
17. Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.
Angelini DJ; Su Q; Yamaji-Kegan K; Fan C; Teng X; Hassoun PM; Yang SC; Champion HC; Tuder RM; Johns RA
Am J Respir Cell Mol Biol; 2009 Nov; 41(5):553-61. PubMed ID: 19251945
[TBL] [Abstract][Full Text] [Related]
18. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J
Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
